XIX International AIDS Conference


Cobicistat versus ritonavir as pharmacoenhancers in combination with atazanavir plus tenofovir disoproxil fumarate/emtricitabine: phase 3 randomized, double blind, active-controlled trial, week 48 results TUAB0103


Time: 11:35
Speaker: Joel Gallant



This text willreplaced

You can download the video file here



For more information on this presentation, including access to speaker presentations, please see the conference Programme-at-a-Glance page.


Contact Us | Site map © 2012 International AIDS Society